The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis

Saved in:
Bibliographic Details
Published inThrombosis and haemostasis Vol. 86; no. 6; p. 1586
Main Authors Smorenburg, S M, Vink, R, Otten, H M, Swaneveld, F, Büller, H R
Format Journal Article
LanguageEnglish
Published Germany 01.12.2001
Subjects
Adenocarcinoma - drug therapy
Adenocarcinoma - mortality
Anticoagulants - therapeutic use
Carcinoma, Small Cell - drug therapy
Carcinoma, Small Cell - mortality
Clinical Trials as Topic
Colorectal Neoplasms - drug therapy
Colorectal Neoplasms - mortality
Heparin - therapeutic use
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - mortality
Neoplasms - blood
Neoplasms - complications
Neoplasms - drug therapy
Neoplasms - mortality
Odds Ratio
Thrombophilia - etiology
Thrombophilia - mortality
Thrombophilia - prevention & control
Vitamin K - antagonists & inhibitors
Online AccessGet more information

Cover

More Information
ISSN:0340-6245
DOI:10.1055/s-0037-1616771